Literature DB >> 9352570

An S-mephenytoin cysteine conjugate identified in urine of extensive but not of poor metabolizers of S-mephenytoin.

G Tybring1, J Nordin, T Bergman, L Bertilsson.   

Abstract

A conjugate of S-mephenytoin excreted in urine of extensive but not of poor metabolizers of S-mephenytoin has previously been reported. This conjugate, which is easily hydrolysed back to S-mephenytoin, has now been isolated and identified in urine from one extensive metabolizer after a single dose of 100 mg racemic mephenytoin. High performance liquid chromatography purification, followed by gas chromatographic, mass spectrometric and amino acid analyses showed that the isolated compound is a cysteine conjugate of S-mephenytoin. The significant mass spectrometric ions have been confirmed in three additional extensive metabolizers of S-mephenytoin, but were not detectable in urine from three poor metabolizer subjects. The exact structure of the conjugate is unknown, but we suggest that an S-N bond between cysteine and S-mephenytoin is formed via an oxidative radical mechanism catalyzed by CYP2C19.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352570     DOI: 10.1097/00008571-199710000-00003

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  2 in total

1.  Mephenytoin as a probe for CYP2C19 phenotyping:effect of sample storage, intra-individual reproducibility and occurrence of adverse events.

Authors:  W J Tamminga; J Wemer; B Oosterhuis; J Wieling; D J Touw; R A de Zeeuw; L F de Leij; J H Jonkman
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

2.  Assessment of urinary mephenytoin metrics to phenotype for CYP2C19 and CYP2B6 activity.

Authors:  Tobias Klaassen; Alexander Jetter; Dorota Tomalik-Scharte; Dirk Kasel; Julia Kirchheiner; Ulrich Jaehde; Uwe Fuhr
Journal:  Eur J Clin Pharmacol       Date:  2007-12-11       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.